Cocrystal Pharma (NASDAQ:COCP) Price Target Cut to $10.00 by Analysts at HC Wainwright
Cocrystal Pharma (NASDAQ:COCP – Free Report) had its target price reduced by HC Wainwright from $12.00 to $10.00 in a report published on Wednesday, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Cocrystal Pharma’s Q4 2023 earnings at ($0.58) EPS, FY2023 earnings at ($2.01) EPS, Q1 […]
More Stories
The Future of AI in Entertainment: How AI Is Changing Online Casinos, Gaming, and Streaming
The entertainment sector is quickly changing with the integration of Artificial Intelligence (AI) by more and more companies – from...
J Heath Deneke Sells 1,000 Shares of Summit Midstream Corporation (NYSE:SMC) Stock
Summit Midstream Corporation (NYSE:SMC – Get Free Report) CEO J Heath Deneke sold 1,000 shares of the firm’s stock in...
Incyte Co. (NASDAQ:INCY) Receives Average Rating of “Hold” from Brokerages
Incyte Co. (NASDAQ:INCY – Get Free Report) has been assigned an average recommendation of “Hold” from the twenty ratings firms...
Eaton Co. plc (NYSE:ETN) Receives Average Rating of “Moderate Buy” from Brokerages
Eaton Co. plc (NYSE:ETN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seventeen...
NextEra Energy Partners, LP (NYSE:NEP) Given Consensus Recommendation of “Hold” by Analysts
NextEra Energy Partners, LP (NYSE:NEP – Get Free Report) has received a consensus rating of “Hold” from the seventeen analysts...
Analysts Set First Solar, Inc. (NASDAQ:FSLR) Target Price at $279.04
Shares of First Solar, Inc. (NASDAQ:FSLR – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the...